Effects of Keishi-ka-jutsubu-to (traditional herbal medicine: Gui-zhi-jia-shu-fu-tang) on in vivo insulin action in streptozotocin-induced diabetic rats

Life Sciences

Volumn 73, Issue 21, 2003, Pages 2687-2701

  Qin, Bolin ^a   Nagasaki, Masaru ^b   Ren, Ming ^a   Bajotto, Gustavo ^a   Oshida, Yoshiharu ^a,b   Sato, Yuzo ^a,b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Euglycemic clamp; Insulin action; Insulin signaling; Keishi ka jutsubu to (KJT); Nitric oxide (NO); Traditional herbal medicine

Indexed keywords

GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; KEISHI KA JUTSUBU TO EXTRACT; N(G) METHYLARGININE; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; GLUCOSE HOMEOSTASIS; GUI ZHI JIA SHU FU TANG; HORMONAL REGULATION; INSULIN CLEARANCE; INSULIN INFUSION; INSULIN SYNTHESIS; LOW DRUG DOSE; MALE; MEDICINAL PLANT; NONHUMAN; PATCH CLAMP; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SKELETAL MUSCLE; SPECIES COMPARISON; STREPTOZOCIN DIABETES;

JIA;

EID: 0141676891     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00640-4     Document Type: Article

References (53)

1. Aita K., Sinndou H., Tawada M., Zyouya T. Effects of kampo medicines on rat lens aldose reductase and sorbitol accumulation in human erythrocytes. Journal of Japanese Hormone and Clinical. 33:1985;75-79.
2. Akazawa S. Effects of Keishi-ka-jutsubu-to extract on diabetic neuropathy. The Journal of Japan Basic and clinical. 15(10):1981;206-210.
3. Akazawa S., Goide A., OOisi M., Tasiro S. Effects of herbal medicines on the polyol metabolism in erythrocytes and platelet function in diabetic patients. Journal of Medical and Pharmaceutical Society for WAKAN-YAKU. 4:1987;310-311.
4. Anai M., Funaki M., Ogihara T., Terasaki J., Inukai K., Katagiri H., Fukushima Y., Yazaki Y., Kikuchi M., Oka Y., Asano T. Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats. Diabetes. 47(1):1998;13-23.
5. Araki E., Lipes M.A., Patti M.E., Bruning J.C., Haag B.R., Johnson R.S., Kahn C.R. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature. 372(6502):1994;186-190.
6. Balon T.W., Nadler J. Evidence that nitric oxide increases glucose transport in skeletal muscle. Journal of Applied Physiology. 82(1):1997;359-363.
7. Bevilacqua S., Barrett E.J., Smith D., Simonson D.C., Olsson M., Bratusch-Marrain P., Ferrannini E., DeFronzo R.A. Hepatic and peripheral insulin resistance following streptozotocin-induced insulin deficiency in the dog. Metabolism. 34(9):1985;817-825.
8. Borchers A., Sakai S., Henderson G., Harkey M., Keen C.L., Stern J., Terasawa K., Gershwin M. Shosaiko-to and other Kampo (Japanese herbal) medicines: a review of their immunomodulatory activities. Journal of Ethnopharmacology. 73(1-2):2000;1-13.
9. Cardillo C., Nambi S., Kilcoyne C., Choucair W., Katz A., Quon M., Panza J. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation. 100(8):1999;820-825.
10. Chan N., Vallance H., Colhoun M. Nitric oxide and vascular responses in type I diabetes. Diabetologia. 43(2):2000;137-147.
11. Chandra D., Jackson E., Ramana K., Kelley R., Srivastava S., Bhatnagar A. Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes. Diabetes. 51(10):2002;3095-3101.
12. Cheatham B., Vlahos C., Cheatham L., Wang L., Blenis J., Kahn C. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Molecular and Cellular Biology. 14(7):1994;4902-4911.
13. DeFronzo R., Bonadonna R., Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 15(3):1992;318-368.
14. Etgen G., Fryburg D., Gibbs E. Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway. Diabetes. 46(11):1997;1915-1919.
15. Folli F., Saad M., Backer J., Kahn C. Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. Journal of Clinical Investigation. 92(4):1993;1787-1794.
16. Gardiner S., Kemp P., March J., Bennett T. Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. British Journal of Pharmacology. 116:1995;2005-2016.
17. Giorgino F.C.J., Smith R.J., Chen J.H. Changes in tyrosine phosphorylation of insulin receptors and a 170,000 molecular weight nonreceptor protein in vivo in skeletal muscle of streptozotoine-induced diabetic rats: effects of insulin and glucose. Endocrinology. 130:1992;1433-1444.
18. Goodyear L., Giorgino F., Sherman L., Carey J., Smith R., Dohm G. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. Journal of Clinical Investigation. 95(5):1995;2195-2204.
19. Holzer S., Camerota A., Martens L., Cuerdon T., Crystalpeters J., Zagari M. Costs and duration of care for lower extremity ulcers in patients with diabetes. Clinical Therapeutics. 20:1998;169-181.
20. Hu X., Sato J., Oshida Y., Xu M., Bajotto G., Sato Y. Effect of Gosha-jinki-gan (Chinese herbal medicine: Niu-Che-Sen-Qi-Wan) on insulin resistance in streptozotocin-induced diabetic rats. Diabetes Research and Clinical Practice. 59(2):2003;103-111.
21. Kahn C. Insulin resistance, insulin insensitivity and insulin unresponsiveness: a necessary distinction. Metabolism. 27:1978;1893-1902.
22. Kimura M., Kimura I., Muroi M., Yoshizaki M., Hikio H. Pharmacological evidence for an interaction between constituents (blend effect) of the Japanese-Sino medicine "Keishi-ka-zyutubu-to" in neuromuscular blockade in diabetic mice. Phytotherapy Research. 1(3):1987;107-113.
23. Klip A., Ramlal T., Bilan P., Cartee G., Gulve E., Holloszy J. Recruitment of GLUT-4 glucose transporters by insulin in diabetic rat skeletal muscle. Biochemical and Biophysical Research Communications. 172(2):1990;728-736.
24. Laviola L., Belsanti G., Davalli A., Napoli R., Perrini S., Weir G., Giorgino R., Giorgino F. Effects of streptozocin diabetes and diabetes treatment by islet transplantation on in vivo insulin signaling in rat heart. Diabetes. 50(12):2001;2709-2720.
25. Li L., Oshida Y., Han Y., Kitakoshi K., Fuku N., Sato Y. Role of nitric oxide in insulin action in STZ-induced diabetic rats-use of euglycaemic clamp technique. The Journal of the Japan Diabetes Society. 43:2000;301-306.
26. Li L., Oshida Y., Kusunoki M., Yamanouchi K., Johansson B., Wahren J., Sato Y. Rat C peptide I and II stimulate glucose utilization in STZ-induced diabetic rats. Diabetologia. 42(8):1999;958-964.
27. Lisato G., Cusin I., Tiengo A., Del Prato S., Jeanrenaud B. The contribution of hyperglycaemia and hypoinsulinaemia to the insulin resistance of streptozotocin-diabetic rats. Diabetologia. 35(4):1992;310-315.
28. Montagnani M., Ravichandran L., Chen H., Esposito D., Quon M. Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. Molecular Endocrinology. 16(8):2002;1931-1942.
29. Montagnani M., Chen H., Barr V.A., Quon M.J. Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser (1179). Journal of Biological Chemistry. 276(32):2001;30392-30398.
30. Nagasaki M., Nakai N., Oshida Y., Li Z., Xu M., Obayashi M., Murakami T., Yoshimura A., Fujitsuka N., Shimomura Y., Sato Y. Exercise training prevents maturation-induced decreases in insulin receptor substrate-1 and phosphatidylinositol 3-kinase in rat skeletal muscle. Metabolism. 49(7):2000;954-959.
31. Nakai N., Shimomura Y., Ohsaki N., Sato J., Oshida Y., Ohsawa I., Fujitsuka N., Sato Y. Exercise training prevents maturation-induced decrease in insulin sensitivity. Journal of Applied Physiology. 80(6):1996;1963-1967.
32. Napoli R., Hirshman M., Horton E. Mechanisms and time course of impaired skeletal muscle glucose transport activity in streptozocin diabetic rats. Journal of Clinical Investigation. 96(1):1995;427-437.
33. Nishizawa M., Sutherland W., Nukada H. Gosha-jinki-gan (herbal medicine) in streptozocin-induced diabetic neuropathy. Journal of the Neurological Sciences. 132(2):1995;177-181.
34. Oakes N., Cooney G., Camilleri S., Chisholm D., Kraegen E. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes. 46(11):1997;1768-1774.
35. Okada T., Kawano Y., Sakakibara T., Hazeki O., Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. Journal of Biological Chemistry. 269(5):1994;3568-3573.
36. Olefsky J., Kolterman O., Scarlett J. Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. American Journal of Physiology. 243:1999;E15-E30.
37. Perreault M., Dombrowski L., Marette A. Mechanism of impaired nitric oxide synthase activity in skeletal muscle of streptozocin-induced diabetic rats. Diabetologia. 43(4):2000;427-437.
38. Petrie J.R., Ueda S., Webb D.J., Elliott H.L., Connell J.M. Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. Circulation. 93(7):1996;1331-1333.
39. Rodella L., Rezzani R., Corsetti G., Bianchi R. Nitric oxide involvement in the trigeminal hyperalgesia in diabetic rats. Brain Research. 865(1):2000;112-115.
40. Roy D., Perreault M., Marette A. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. American Journal of Physiology. 274(4 Pt 1):1998;E692-E699.
41. Saad M., Araki E., Miralpeix M., Rothenberg P., White M., Kahn C. Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. Journal of Clinical Investigation. 90(5):1992;1839-1849.
42. Sasaki T., Yasuda H., Maeda K., Kikkawa R. Hyperalgesia and decreased neuronal nitric oxide synthase in diabetic rats. Neuroreport. 9(2):1998;243-247.
43. Shankar R., Zhu J.S., Ladd B., Henry D., Shen H.Q., Baron A.D. Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action. Journal of Clinical Investigation. 102(7):1998;1403-1412.
44. Shikano M., Niwa T. Effect of Chinese Medicine in Diabetic Patients. Biomedical Thermography. 7(1):1987;176-179.
45. Smith D., Rossetti L., Ferrannini E., Johnson C.M., Cobelli C., Toffolo G., Katz L.D., DeFronzo R. In vivo glucose metabolism in the awake rat: tracer and insulin clamp studies. Metabolism. 36(12):1987;1167-1174.
46. Steinberg H., Chaker H., Leaming R., Johnson A., Brechtel G., Baron A. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. Journal of Clinical Investigation. 97(11):1996;2601-2610.
47. Tamemoto H., Kadowaki T., Tobe K., Yagi T., Sakura H., Hayakawa T., Terauchi Y., Ueki K., Kaburagi Y., Satoh S.et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 372(6502):1994;182-186.
48. Tominaga M., Kimura M., Sugiyama K., Abe T., Igarashi K., Igarashi M., Eguchi H., Sekikawa A., Ogawa A., Manaka H.et al. Effects of seishin-renshi-in and Gymnema sylvestre on insulin resistance in streptozotocin-induced diabetic rats. Diabetes Research Clinical Practice. 29(1):1995;11-17.
49. Toriizuka M. The pharmacological action of kampo herbal prescription- Keishi-ka-jutsubu-to. Kampo medicine. 21(6):1997;184-189.
50. Vinik A., Mitchell B., Leichter S., Wagner A., O'Brian J., Georges L. Epidemiology of the Complications of Diabetes. Clinical Science in practice. 1995;221-287 Cambridge University Press, Cambridge.
51. Yamauchi T., Tobe K., Tamemoto H., Ueki K., Kaburagi Y., Yamamoto-Honda R., Takahashi Y., Yoshizawa F., Aizawa S., Akanuma Y., Sonenberg N., Yazaki Y., Kadowaki T. Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice. Molecular and Cellular Biollogy. 16(6):1996;3074-3084.
52. Zeng G., Nystrom F., Ravichandran L., Cong L., Kirby M., Mostowski H., Quon M. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation. 101(13):2000;1539-1545.
53. Zeng G., Quon M. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. Journal of Clinical Investigation. 98(4):1996;894-898.